To understand the mechanism underlying the protective effects of fucoidan against ethanol-induced liver injury and steatosis, we analyzed the hepatic expression of p-AMPKα, SIRT1, ChREBP, PGC-1α, and HNF-1α, which regulate hepatic fat metabolism and inflammatory response. Here, MLXIPL is linked to steatosis.